Table 2.

Effect of the agonist ACPD on the amplitudes of evoked IPSCs (percentage of the 1st IPSC in control group) in A1

L4-L2/3	Effect of ACPD, % of the 1st Control IPSC		GDPβS in the Intracellular Solution, % of the 1st Control IPSC		L4-L4	Effect of ACPD, % of the 1st Control IPSC		GDPβS in the Intracellular Solution, % of the 1st Control IPSC
Average ±SE	Control	ACPD	Control	ACPD	Average ±SE	Control	ACPD	Control	ACPD
IPSC1	100	39.3 ± 11.2*	100	57.6 ± 8.5†	IPSC1	100	46.5 ± 7.1†	100	54.3 ± 5.4*
IPSC2	79.5 ± 3.2	32.9 ± 7.8*	74.6 ± 4.3	42.8 ± 4.8†	IPSC2	92.0 ± 9.0	43.6 ± 6.5†	98.4 ± 7.8	55.2 ± 6.6*
IPSC3	68.1 ± 3.0	30.9 ± 6.9*	62.3 ± 6.4	39.8 ± 3.0*	IPSC3	84.9 ± 10.2	40.2 ± 6.2†	98.4 ± 10.4	56.6 ± 5.5*
IPSC4	59.5 ± 2.5	29.1 ± 6.9†	51.7 ± 5.9	34.8 ± 2.8*	IPSC4	77.6 ± 9.5	37.4 ± 5.9†	90.8 ± 9.7	63.7 ± 9.6*

^*P < 0.05,

^†P < 0.01.